Natures Sunshine Products Inc SEC filings NATR
Natures Sunshine Products Inc has 1,002 filings in SEC EDGAR's recent list, going back to Jun 21, 2011. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 20, 2026 | — |
| DEFA14A | Additional proxy material | Mar 27, 2026 | — |
| DEF 14A | Proxy statement | Mar 27, 2026 | Mar 27, 2026 |
| DEF 14A | Proxy statement | Mar 20, 2025 | Mar 20, 2025 |
| DEFA14A | Additional proxy material | Mar 15, 2024 | — |
| DEF 14A | Proxy statement | Mar 15, 2024 | May 1, 2024 |
| DEFA14A | Additional proxy material | Mar 24, 2023 | — |
| DEF 14A | Proxy statement | Mar 24, 2023 | Mar 24, 2023 |
| DEFA14A | Additional proxy material | Mar 18, 2022 | — |
| DEF 14A | Proxy statement | Mar 18, 2022 | Dec 31, 2021 |
| DEF 14A | Proxy statement | Mar 19, 2021 | Dec 31, 2020 |
| DEFA14A | Additional proxy material | May 1, 2020 | — |
| DEFA14A | Additional proxy material | Mar 27, 2020 | — |
| DEF 14A | Proxy statement | Mar 27, 2020 | May 6, 2020 |
| DEFA14A | Additional proxy material | Mar 22, 2019 | — |
| DEF 14A | Proxy statement | Mar 22, 2019 | May 8, 2019 |
| DEF 14A | Proxy statement | Mar 26, 2018 | May 2, 2018 |
| DEFA14A | Additional proxy material | Mar 24, 2017 | — |
| DEF 14A | Proxy statement | Mar 24, 2017 | May 9, 2017 |
| DEFA14A | Additional proxy material | Apr 14, 2016 | — |
| DEF 14A | Proxy statement | Apr 14, 2016 | Dec 31, 2015 |
| PRE 14A | Preliminary proxy statement | Mar 15, 2016 | Dec 31, 2015 |
| DEFA14A | Additional proxy material | Mar 27, 2015 | — |
| DEF 14A | Proxy statement | Mar 27, 2015 | May 6, 2015 |
| DEF 14A | Proxy statement | Dec 12, 2014 | Jan 14, 2015 |
| DEFA14A | Additional proxy material | Mar 28, 2014 | — |
| DEF 14A | Proxy statement | Mar 28, 2014 | May 7, 2014 |
| DEFA14A | Additional proxy material | Mar 29, 2013 | — |
| DEF 14A | Proxy statement | Mar 29, 2013 | May 8, 2013 |
| PRE 14A | Preliminary proxy statement | Mar 8, 2013 | May 8, 2013 |
| DEFA14A | Additional proxy material | Jun 18, 2012 | — |
| DEF 14A | Proxy statement | Apr 30, 2012 | Aug 1, 2012 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NATR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- Lehi, UT
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 275053
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.